Management of important adverse events associated with inotuzumab ozogamicin: expert panel review. Academic Article uri icon

Overview

publication date

  • January 12, 2018

Research

keywords

  • Antibodies, Monoclonal, Humanized
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Salvage Therapy

Identity

PubMed Central ID

  • PMC5897380

Scopus Document Identifier

  • 85040318688

Digital Object Identifier (DOI)

  • 10.1038/s41409-017-0019-y

PubMed ID

  • 29330398

Additional Document Info

volume

  • 53

issue

  • 4